Czock David, Markert Christoph, Hartman Bertram, Keller Frieder
Department of Internal Medicine VI, Clinical Pharmacology and Pharmacoepidemiology, University Hospital Heidelberg, Heidelberg, Germany.
Expert Opin Drug Metab Toxicol. 2009 May;5(5):475-87. doi: 10.1517/17425250902913808.
Antimicrobial drugs exhibit different characteristics in their correlation between antimicrobial drug concentrations and effects on microorganisms. These correlations have been studied using different approaches including in vitro analyses with constant and fluctuating concentrations and in vivo analyses involving animals and humans. Mathematical analysis includes correlation of pharmacokinetic-pharmacodynamic (PK-PD) indices to an outcome parameter. Further insight can be gained by mechanism-based modelling of antimicrobial drug effects.
This review aims to provide an overview on the various approaches used to analyse antimicrobial pharmacodynamics, to discuss the limitations of these approaches, to indicate recent developments and to summarise the current knowledge on PK-PD target values as derived from human studies.
It is expected that PK-PD analysis of antimicrobial drug effects will lead to a more efficient and possibly also less toxic antimicrobial drug therapy.
抗菌药物在抗菌药物浓度与对微生物的作用之间的相关性方面表现出不同的特征。这些相关性已通过不同方法进行研究,包括使用恒定和波动浓度的体外分析以及涉及动物和人类的体内分析。数学分析包括药代动力学-药效学(PK-PD)指标与结果参数的相关性。通过基于机制的抗菌药物作用建模可以获得更深入的见解。
本综述旨在概述用于分析抗菌药物药效学的各种方法,讨论这些方法的局限性,指出近期的发展,并总结来自人体研究的关于PK-PD目标值的当前知识。
预计对抗菌药物作用的PK-PD分析将导致更有效且可能毒性更低的抗菌药物治疗。